Benitec Biopharma (BLT) Income Statement

Click line-items for a historical chart and %

Consolidated Statements of Income
Sales	209.17M
Cost of sales	150.27M
Gross profit	58.9M
Selling, general, and administrative expenses	41.31M
Operating income	14.14M
Interest income	13K
Interest expense	-3.51M
Other expense, net	-1.89M
Income from continuing operations before income taxes	8.76M
Provision for income taxes	-3.5M
Income from continuing operations
Discontinued operations:
Income from discontinued operations before income taxes
Provision for income taxes
Income from discontinued operations
Net income	12.27M
Basic income per share:
Continuing operations
Discontinued operations
Net income	0.25
Diluted income per share:
Continuing operations
Discontinued operations
Net income	0.25
Weighted average shares used in per share calculations:
Basic	48.48M
Diluted	48.64M

Entities mentioned with BLT